Kosuke Iwasaki

1.4k total citations
62 papers, 995 citations indexed

About

Kosuke Iwasaki is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kosuke Iwasaki has authored 62 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kosuke Iwasaki's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Kosuke Iwasaki is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Kosuke Iwasaki collaborates with scholars based in Japan, United States and Switzerland. Kosuke Iwasaki's co-authors include Bruce Pyenson, Kathryn Fitch, Carol Spence, Stephen R. Connor, Shinzo Hiroi, Kathleen F. Villa, Reiko Sato, Craig Plauschinat, Jie Zhang and Rosarin Sruamsiri and has published in prestigious journals such as Blood, Gastroenterology and Journal of the Neurological Sciences.

In The Last Decade

Kosuke Iwasaki

59 papers receiving 956 citations

Peers

Kosuke Iwasaki
Myrick C. Shinall United States
Yongling Xiao United States
Rodrigo Antonini Ribeiro Brazil
Anna Francis Australia
KoKo Aung United States
Zhan Yao Canada
Caterina Caminiti Italy
Juan Garduño‐Espinosa Mexico
Kiheon Lee South Korea
Christopher Zacker United States
Myrick C. Shinall United States
Kosuke Iwasaki
Citations per year, relative to Kosuke Iwasaki Kosuke Iwasaki (= 1×) peers Myrick C. Shinall

Countries citing papers authored by Kosuke Iwasaki

Since Specialization
Citations

This map shows the geographic impact of Kosuke Iwasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Iwasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Iwasaki more than expected).

Fields of papers citing papers by Kosuke Iwasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Iwasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Iwasaki. The network helps show where Kosuke Iwasaki may publish in the future.

Co-authorship network of co-authors of Kosuke Iwasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Iwasaki. A scholar is included among the top collaborators of Kosuke Iwasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Iwasaki. Kosuke Iwasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamamoto, Yosuke, et al.. (2023). Prevalence, treatment status, medical costs, quality of life, and productivity loss in Japanese adult patients with anemia: a real-world database study. Journal of Medical Economics. 26(1). 1386–1397. 3 indexed citations
3.
Izumi, Chisato, et al.. (2023). Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019. Journal of Cardiology. 82(1). 29–34. 9 indexed citations
4.
Shimizu, Eiji, et al.. (2022). Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan. Influenza and Other Respiratory Viruses. 16(4). 621–625. 3 indexed citations
5.
6.
Eguchi, Shunsuke, Hironobu Mitani, Kosuke Iwasaki, et al.. (2022). Burden of Repeated Hospitalizations on Patients with Heart Failure: An Analysis of Administrative and Claims Data in Japan. Drugs - Real World Outcomes. 9(3). 377–389. 5 indexed citations
7.
Hiroi, Shinzo, et al.. (2022). Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses. Advances in Therapy. 39(4). 1724–1742. 5 indexed citations
8.
Kawachi, Izumi, et al.. (2022). A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data. Neurology and Therapy. 11(1). 385–396. 1 indexed citations
9.
Suda, Takafumi, et al.. (2022). Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis. Respiratory Investigation. 60(6). 806–814. 4 indexed citations
10.
Kondoh, Yasuhiro, et al.. (2022). Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis. Respiratory Research. 23(1). 24–24. 17 indexed citations
11.
12.
Nagai, Yoshio, et al.. (2021). A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes. Diabetes Therapy. 12(4). 1129–1141. 4 indexed citations
13.
14.
Nishimura, Rimei, et al.. (2021). Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis. Advances in Therapy. 39(1). 632–654. 5 indexed citations
15.
Kawachi, Izumi, Shu‐ichi Okamoto, Hiroyuki Ohta, et al.. (2019). Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database. BMC Neurology. 19(1). 324–324. 7 indexed citations
16.
Iwaki, Hirotaka, Masaaki Tagawa, Kosuke Iwasaki, Koji Kawakami, & Masahiro Nomoto. (2019). Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms. Journal of the Neurological Sciences. 402. 145–152. 7 indexed citations
17.
Ueno, Tetsuo, Hiromitsu Yabushita, Kosuke Iwasaki, & Akihiko Wakatsuki. (2018). Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer. European Journal of Gynaecological Oncology. 39(2). 199–204. 2 indexed citations
18.
19.
Ogino, Mieko, Izumi Kawachi, Kazuyoshi Otake, et al.. (2016). Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database. Clinical and Experimental Neuroimmunology. 7(2). 158–167. 14 indexed citations
20.
Fitch, Kathryn, Bruce Pyenson, & Kosuke Iwasaki. (2013). Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes. Journal of Managed Care Pharmacy. 19(8). 609–620. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myrick C. Shinall Breakdown of academic impact, for papers by Yongling Xiao Breakdown of academic impact, for papers by Rodrigo Antonini Ribeiro Breakdown of academic impact, for papers by Anna Francis Breakdown of academic impact, for papers by KoKo Aung Breakdown of academic impact, for papers by Zhan Yao Breakdown of academic impact, for papers by Caterina Caminiti Breakdown of academic impact, for papers by Juan Garduño‐Espinosa Breakdown of academic impact, for papers by Kiheon Lee Breakdown of academic impact, for papers by Christopher Zacker
Rankless by CCL
2026